We suggested that upregulation of TGFBR1 reduced proinflammatory and cytokine gene signatures such as CCL8, CCL11, CXCL10, and TNFSF12 leading to inhibition of T-reg cell death in CRC patients. This evidence concerns the gene TGFBR1 and colorectal carcinoma.